Mayne Pharma | MYX - Ordinary Share Capital


Mayne Pharma reported AUD81.25M in Ordinary Share Capital for its fiscal semester ending in June of 2025.





Ordinary Share Capital Change Date
Ansell USD 142.94M 885.26M Dec/2025
Cochlear AUD 65.4M 1.12B Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Healius AUD 2.6B 100K Dec/2024
Integral Diagnostics AUD 335.09M 1.07M Jun/2024
Medical Developments International AUD 112.66M 2.35M Dec/2025
Nanosonics AUD 303.35M 188.61M Dec/2025
Polynovo AUD 690.84M 991 Dec/2025
Ramsay Health Care AUD 229.93M 29.81K Dec/2025
ResMed USD 145.04M 621.52K Mar/2026
Sigma Healthcare AUD 11.5B 9.93B Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Telix Pharmaceuticals AUD 339.78M 1.01M Jun/2026